Results 131 to 140 of about 2,890 (187)

Novel missense variants associated with GNE myopathy

open access: yes
Ranta-aho J   +19 more
europepmc   +1 more source

Comparison of Lectins as Staining Biomarkers for GNE Myopathy Gene Therapy

open access: closedThe FASEB Journal, 2022
GNE myopathy (GNEM) is an autosomal recessive disease in which mutations in the GNE gene lead to skeletal muscle weakness and progressive wasting. GNE encodes an essential enzyme of the sialic acid (SA) biosynthetic pathway; thus, decreased SA levels in
Kelly E. Crowe
openalex   +2 more sources

Disease mechanisms associated with mutations of the GNE gene

open access: closedDrug Discovery Today: Disease Mechanisms, 2005
The GNE gene encodes the rate-limiting, bifunctional enzyme of sialic acid biosynthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase. GNE mutations underlie two distinct disorders, dominant inherited sialuria characterized by dramatically increased sialic acid levels and recessive hereditary inclusion body myopathy (HIBM), characterized by decreased ...
Marjan Huizing
openalex   +2 more sources

Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy

open access: closedThe Journal of Gene Medicine, 2010
AbstractBackgroundHereditary inclusion body myopathy (HIBM) is an autosomal recessive adult onset myopathy. It is characterized by mutations of the GNE (UDP‐N‐acetylglucosamine 2‐epimerase/N‐acetylmannosamine kinase) gene. Afflicted patients have no therapeutic options.
Gregory Nemunaitis   +13 more
openalex   +3 more sources

An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene

open access: closedNeurology, 2002
The term hereditary inclusion-body myopathies (h-IBM) refers to several syndromes with autosomal recessive (AR) or dominant inheritance.1 Although clinical presentation may vary among different forms, they all lead to severe disability and share common findings at muscle biopsy.
Aldobrando Broccolini   +8 more
openalex   +4 more sources

GENE VARIANTS ASSOCIATED WITH THROMBOCYTOPENIA WITH OR WITHOUT GNE MYOPATHY

open access: closedMolecular Genetics and Metabolism, 2022
Jessica Jang   +6 more
openalex   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Tissue-specific isoform expression of GNE gene in human tissues

Journal of Muscle Research and Cell Motility, 2022
Mutations in the sialic acid biosynthesis enzyme GNE lead to a late-onset, debilitating neuromuscular disorder, GNE myopathy, characterized by progressive skeletal muscle weakness. The mechanisms responsible for skeletal muscle specificity, late-onset, and disease progression are unknown.
Kapila Awasthi   +2 more
openaire   +2 more sources

Gene analysis and clinical features of 22 GNE myopathy patients

Neurological Sciences, 2022
GNE myopathy is an autosomal recessive distal myopathy caused by a biallelic mutation in UDP-N-acetylglucosamine 2-epomerase/N-acetylmannosamine kinase. In this study, we discuss the clinical features, pathological characteristics, genetic profiles, and atypical clinical manifestations of 22 Chinese GNE patients.Retrospective analysis was performed for
Xuan Guo   +6 more
openaire   +2 more sources

Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy)

Journal of Neurology, Neurosurgery & Psychiatry, 2013
GNE myopathy (also called distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy) is an autosomal recessive myopathy characterised by skeletal muscle atrophy and weakness that preferentially involve the distal muscles. It is caused by mutations in the gene encoding a key enzyme in sialic acid biosynthesis, UDP-N-acetylglucosamine 2 ...
Anna, Cho   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy